3ebf: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
 
(16 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Seed}}
[[Image:3ebf.jpg|left|200px]]


<!--
==Structure of inhibited murine iNOS oxygenase domain==
The line below this paragraph, containing "STRUCTURE_3ebf", creates the "Structure Box" on the page.
<StructureSection load='3ebf' size='340' side='right'caption='[[3ebf]], [[Resolution|resolution]] 2.29&Aring;' scene=''>
You may change the PDB parameter (which sets the PDB file loaded into the applet)
== Structural highlights ==
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
<table><tr><td colspan='2'>[[3ebf]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3EBF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3EBF FirstGlance]. <br>
or leave the SCENE parameter empty for the default display.
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.29&#8491;</td></tr>
-->
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=332:(3R)-3-[(1,2,3,4-TETRAHYDROISOQUINOLIN-7-YLOXY)METHYL]-2,3-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5-AMINE'>332</scene>, <scene name='pdbligand=H4B:5,6,7,8-TETRAHYDROBIOPTERIN'>H4B</scene>, <scene name='pdbligand=HEM:PROTOPORPHYRIN+IX+CONTAINING+FE'>HEM</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
{{STRUCTURE_3ebf|  PDB=3ebf  |  SCENE=  }}
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3ebf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3ebf OCA], [https://pdbe.org/3ebf PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3ebf RCSB], [https://www.ebi.ac.uk/pdbsum/3ebf PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3ebf ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/NOS2_MOUSE NOS2_MOUSE] Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. In macrophages, NO mediates tumoricidal and bactericidal actions. Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such COX2.<ref>PMID:16373578</ref>
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
Check<jmol>
  <jmolCheckbox>
    <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/eb/3ebf_consurf.spt"</scriptWhenChecked>
    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview03.spt</scriptWhenUnchecked>
    <text>to colour the structure by Evolutionary Conservation</text>
  </jmolCheckbox>
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=3ebf ConSurf].
<div style="clear:both"></div>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Nitric oxide synthase (NOS) enzymes synthesize nitric oxide, a signal for vasodilatation and neurotransmission at low concentrations and a defensive cytotoxin at higher concentrations. The high active site conservation among all three NOS isozymes hinders the design of selective NOS inhibitors to treat inflammation, arthritis, stroke, septic shock and cancer. Our crystal structures and mutagenesis results identified an isozyme-specific induced-fit binding mode linking a cascade of conformational changes to a new specificity pocket. Plasticity of an isozyme-specific triad of distant second- and third-shell residues modulates conformational changes of invariant first-shell residues to determine inhibitor selectivity. To design potent and selective NOS inhibitors, we developed the anchored plasticity approach: anchor an inhibitor core in a conserved binding pocket, then extend rigid bulky substituents toward remote specificity pockets, which become accessible upon conformational changes of flexible residues. This approach exemplifies general principles for the design of selective enzyme inhibitors that overcome strong active site conservation.


===Structure of inhibited murine iNOS oxygenase domain===
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.,Garcin ED, Arvai AS, Rosenfeld RJ, Kroeger MD, Crane BR, Andersson G, Andrews G, Hamley PJ, Mallinder PR, Nicholls DJ, St-Gallay SA, Tinker AC, Gensmantel NP, Mete A, Cheshire DR, Connolly S, Stuehr DJ, Aberg A, Wallace AV, Tainer JA, Getzoff ED Nat Chem Biol. 2008 Nov;4(11):700-7. Epub 2008 Oct 12. PMID:18849972<ref>PMID:18849972</ref>


From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 3ebf" style="background-color:#fffaf0;"></div>


==About this Structure==
==See Also==
3EBF is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3EBF OCA].
*[[Nitric Oxide Synthase 3D structures|Nitric Oxide Synthase 3D structures]]
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Large Structures]]
[[Category: Mus musculus]]
[[Category: Mus musculus]]
[[Category: Nitric-oxide synthase]]
[[Category: Aberg A]]
[[Category: Single protein]]
[[Category: Andersson G]]
[[Category: Aberg, A.]]
[[Category: Andrews G]]
[[Category: Andersson, G.]]
[[Category: Arvai AS]]
[[Category: Andrews, G.]]
[[Category: Cheshire DR]]
[[Category: Arvai, A S.]]
[[Category: Connolly S]]
[[Category: Cheshire, D R.]]
[[Category: Crane BR]]
[[Category: Connolly, S.]]
[[Category: Garcin ED]]
[[Category: Crane, B R.]]
[[Category: Gensmantel NP]]
[[Category: Garcin, E D.]]
[[Category: Getzoff ED]]
[[Category: Gensmantel, N P.]]
[[Category: Hamley PJ]]
[[Category: Getzoff, E D.]]
[[Category: Kroeger MD]]
[[Category: Hamley, P J.]]
[[Category: Mallinder PR]]
[[Category: Kroeger, M D.]]
[[Category: Mete A]]
[[Category: Mallinder, P R.]]
[[Category: Nicholls DJ]]
[[Category: Mete, A.]]
[[Category: Rosenfeld RJ]]
[[Category: Nicholls, D J.]]
[[Category: St-Gallay SA]]
[[Category: Rosenfeld, R J.]]
[[Category: Stuehr DJ]]
[[Category: St-Gallay, S A.]]
[[Category: Tainer JA]]
[[Category: Stuehr, D J.]]
[[Category: Tinker AC]]
[[Category: Tainer, J A.]]
[[Category: Wallace AV]]
[[Category: Tinker, A C.]]
[[Category: Wallace, A V.]]
[[Category: Fad]]
[[Category: Fmn]]
[[Category: Heme]]
[[Category: Iron]]
[[Category: Metal-binding]]
[[Category: Nadp]]
[[Category: Nitric oxide synthase]]
[[Category: No]]
[[Category: Oxidoreductase]]
[[Category: Oxidoreductase calmodulin-binding]]
[[Category: Polymorphism]]
[[Category: Tetrahydrobiopterin]]
[[Category: Zinc]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Oct  8 09:35:43 2008''